E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis

Journal of Clinical Investigation

Volumn 126, Issue 1, 2016, Pages 137-150

  Denechaud, Pierre Damien ^a   Lopez Mejia, Isabel C ^a   Giralt, Albert ^a   Lai, Qiuwen ^a   Blanchet, Emilie ^b   Delacuisine, Brigitte ^a   Nicolay, Brandon N ^c   Dyson, Nicholas J ^c   Bonner, Caroline ^d,e,f   Pattou, François ^d,e,f   Annicotte, Jean Sébastien ^b,g   Fajas, Lluis ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIV MONTPELLIER   (France)

^c HARVARD MEDICAL SCHOOL   (United States)

^d France   (France)

^e INSERM UMR 1190 ^*  (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; FATTY ACID; GLUCOSE; INSULIN; TRANSCRIPTION FACTOR E2F1; E2F1 PROTEIN, HUMAN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY LIVER; FEMALE; GENE DELETION; GENE EXPRESSION; GLYCOLYSIS; HUMAN; LIPOGENESIS; LIVER BIOPSY; LIVER CELL; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; DNA RESPONSIVE ELEMENT; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PHYSIOLOGY;

ANIMALS; CYCLIN-DEPENDENT KINASE 4; E2F1 TRANSCRIPTION FACTOR; GLYCOLYSIS; HUMANS; LIPOGENESIS; LIVER; MICE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; RESPONSE ELEMENTS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84956695797     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI81542     Document Type: Article

References (41)

1. Dimova DK, Dyson NJ. The E2F transcriptional network: old acquaintances with new faces. Oncogene. 2005;24(17):2810-2826.
2. Annicotte JS, et al. The CDK4-pRB-E2F1 pathway controls insulin secretion. Nat Cell Biol. 2009;11(8):1017-1023.
3. Fajas L, Landsberg RL, Huss-Garcia Y, Sardet C, Lees JA, Auwerx J. E2Fs regulate adipocyte differentiation. Dev Cell. 2002;3(1):39-49.
4. Blanchet E, et al. E2F transcription factor-1 regulates oxidative metabolism. Nat Cell Biol. 2011;13(9):1146-1152.
5. Hsieh MC, Das D, Sambandam N, Zhang MQ, Nahle Z. Regulation of the PDK4 isozyme by the Rb-E2F1 complex. J Biol Chem. 2008;283(41):27410-27417.
6. Fernandez de Mattos S, Lam EW, Tauler A. An E2F-binding site mediates the activation of the proliferative isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase by phosphatidylinositol 3-kinase. Biochem J. 2002;368(pt 1):283-291.
7. Dali-Youcef N, et al. Adipose tissue-specific inactivation of the retinoblastoma protein protects against diabesity because of increased energy expenditure. Proc Natl Acad Sci U S A. 2007;104(25):10703-10708.
8. Nicolay BN, et al. Loss of RBF1 changes glutamine catabolism. Genes Dev. 2013;27(2):182-196.
9. Lopez-Mejia IC, Fajas L. Cell cycle regulation of mitochondrial function. Curr Opin Cell Biol. 2015;33:19-25.
10. Conner EA, Lemmer ER, Omori M, Wirth PJ, Factor VM, Thorgeirsson SS. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis. Oncogene. 2000;19(44):5054-5062.
11. Zhang Y, et al. E2F1 is a novel fibrogenic gene that regulates cholestatic liver fibrosis through the Egr-1/SHP/EID1 network. Hepatology. 2014;60(3):919-930.
12. Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest. 2008;118(3):829-838.
13. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997;89(3):331-340.
14. Foretz M, Guichard C, Ferré P, Foufelle F. Sterol regulatory element binding protein 1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci U S A. 1999;96(22):12737-12742.
15. Denechaud PD, et al. ChREBP, but not LXRs, is required for the induction of glucoseregulated genes in mouse liver. J Clin Invest. 2008;118(3):956-964.
16. Chan SM, et al. Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress. Diabetes. 2013;62(6):2095-2105.
17. David FP, et al. HTSstation: A web application and open-access libraries for high-throughput sequencing data analysis. PLoS One. 2014;9(1):e85879.
18. Cao AR, Rabinovich R, Xu M, Xu X, Jin VX, Farnham PJ. Genome-wide analysis of transcription factor E2F1 mutant proteins reveals that N-and C-terminal protein interaction domains do not participate in targeting E2F1 to the human genome. J Biol Chem. 2011;286(14):11985-11996.
19. Wong RH, Chang I, Hudak CS, Hyun S, Kwan HY, Sul HS. A role of DNA-PK for the metabolic gene regulation in response to insulin. Cell. 2009;136(6):1056-1072.
20. Yeh MM, Brunt EM. Pathological features of fatty liver disease. Gastroenterology. 2014;147(4):754-764.
21. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115(5):1343-1351.
22. Dentin R, et al. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes. 2006;55(8):2159-2170.
23. Neschen S, et al. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice. Cell Metab. 2005;2(1):55-65.
24. Moon YA, et al. The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals. Cell Metab. 2012;15(2):240-246.
25. Guo S, et al. The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis. Mol Cell Biol. 2009;29(18):5070-5083.
26. Nakamura A, et al. Protection from non-alcoholic steatohepatitis and liver tumourigenesis in high fat-fed insulin receptor substrate-1-knockout mice despite insulin resistance. Diabetologia. 2012;55(12):3382-3391.
27. Chattopadhyay M, Selinger ES, Ballou LM, Lin RZ. Ablation of PI3K p110-alpha prevents high-fat diet-induced liver steatosis. Diabetes. 2011;60(5):1483-1492.
28. Benhamed F, et al. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J Clin Invest. 2012;122(6):2176-2194.
29. Horie Y, et al. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J Clin Invest. 2004;113(12):1774-1783.
30. Brown MS, Goldstein JL. Selective versus total insulin resistance: A pathogenic paradox. Cell Metab. 2008;7(2):95-96.
31. Biddinger SB, et al. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab. 2008;7(2):125-134.
32. Semple RK, et al. Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest. 2009;119(2):315-322.
33. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115(5):1111-1119.
34. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860-867.
35. Ozcan U, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 2006;313(5790):1137-1140.
36. Kammoun HL, et al. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest. 2009;119(5):1201-1215.
37. Bhatia B, Hsieh M, Kenney AM, Nahle Z. Mitogenic Sonic hedgehog signaling drives E2F1-dependent lipogenesis in progenitor cells and medulloblastoma. Oncogene. 2011;30(4):410-422.
38. Scaglia N, Tyekucheva S, Zadra G, Photopoulos C, Loda M. De novo fatty acid synthesis at the mitotic exit is required to complete cellular division. Cell Cycle. 2014;13(5):859-868.
39. Viollet B, Lefrancois-Martinez AM, Henrion A, Kahn A, Raymondjean M, Martinez A. Immunochemical characterization and transacting properties of upstream stimulatory factor isoforms. J Biol Chem. 1996;271(3):1405-1415.
40. Oosterveer MH, et al. LRH-1-dependent glucose sensing determines intermediary metabolism in liver. J Clin Invest. 2012;122(8):2817-2826.
41. Im SS, et al. Glucose-stimulated upregulation of GLUT2 gene is mediated by sterol response element-binding protein-1c in the hepatocytes. Diabetes. 2005;54(6):1684-1691.